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Abstract
© 2018 Akhmadishina, Garifullin, Petrova, Kamalov and Abdullin. Although delocalized lipophilic
cations have been identified as effective cellular and mitochondrial  carriers for a range of
natural and synthetic drug molecules, little is known about their effects on pharmacological
properties  of  peptides.  The  effect  of  triphenylphosphonium (TPP)  cation  on  bioactivity  of
antioxidant tetrapeptides based on the model opioid YRFK motif was studied. Two tetrapeptide
variants  with  L-arginine  (YRFK)  and  D-arginine  (YrFK)  were  synthesized  and  coupled  with
carboxyethyl-TPP  (TPP-3)  and  carboxypentyl-TPP  (TPP-6)  units.  The  TPP  moiety  noticeably
promoted YRFK cleavage by trypsin, but effectively prevented digestion of more resistant YrFK
attributed,  respectively,  to  structure-organizing  and shielding  effects  of  the  TPP  cation  on
conformational variants of the tetrapeptide motif. The TPP moiety enhanced radical scavenging
activity of the modified YRFK in a model Fenton-like reaction, whereas decreased reactivity was
revealed for both YrFK and its TPP derivative. The starting motifs and modified oligopeptides,
especially  the TPP-6 derivatives,  suppressed acute oxidative stress in neuronal  PC-12 cells
during a brief exposure similarly with glutathione. The effect of oligopeptides was compared
upon culturing of PC-12 cells with CoCl2, L-glutamic acid, or menadione to mimic physiologically
relevant oxidative states. The cytoprotective activity of oligopeptides significantly depended on
the  type  of  oxidative  factor,  order  of  treatment  and  peptide  structure.  Pronounced  cell-
protective effect was established for the TPP-modified oligopeptides, which surpassed that of
the unmodified motifs. The protease-resistant TPP-modified YrFK showed the highest activity
when administered 24 h prior to the cell damage. Our results suggest that the TPP cation can be
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